| 产品详情 |
| Edit |   |
|---|
| Product Name | CytoSelect 24-well Cell Migration Assay (8 um), Fluorometric |
|---|
| Description | Background: Cell migration is a highly integrated, multistep process that orchestrates embryonic morphogenesis, tissue repair and regeneration. It plays a pivotal role in the disease progression of cancer, mental retardation, atherosclerosis, and arthritis. The initial response of a cell to a migration-promoting agent is to polarize and extend protrusions in the direction of the attractant; these protrusions can consist of large, broad lamellipodia or spike-like filopodia. In either case, these |
|---|
| Size | 4 assays, 12 assays, 60 assays, |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | MBS168379 |
|---|
| Price | |
|---|
| Order / More Info | CytoSelect 24-well Cell Migration Assay (8 um), Fluorometric from MYBIOSOURCE INC. |
|---|
| Product Specific References | 1. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. (2003) Science 302:1704-9.2. Horwitz R, Webb D. (2003) Curr Biol. 13:R756-9.3. Lauffenburger DA, Horwitz AF. (1996) Cell 84:359-369.1. Izhak, L. et al. (2010). Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner. J. Immunol. 184:1092-1101.2. Wang, W. et al. (2009). Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor. Am. J. Physiol. Renal Physiol. 296:F723-729.3. Izhak, L. et al. (2009). A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological acitivity of CCL2. J. Immunol. 183:732-739.4. Zhao, L. et al. (2008). CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28:1283-1289.5. Fava, G. et al. (2008). Leptin enhances cholangiocarcinoma cell growth. Cancer Res. 68:6752-6761.6. Uddin, M. et al. (2008). Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 29(3):266-273.7. Reing, J. et al. (2008). Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng. Part A 10.1089/ten.tea.2007.0425. |
|---|
| 产品资料 |
|
|